By Aaron Vehling ( May 5, 2014, 5:35 PM EDT) -- Lupin Pharmaceuticals Inc. sued the U.S. Food and Drug Administration in Maryland federal court Friday over the agency's decision to grant another drug company exclusivity to make a generic version of Pfizer Inc.'s Celebrex, arguing the decision was wrong because the exclusivity period had already expired five years ago....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.